Cargando…

Transcranial Direct Current Stimulation (tDCS) for Depression during Pregnancy: Results from an Open-Label Pilot Study

Introduction: Depression is the most common morbidity during pregnancy. Available first-line therapy options are limited and depressive disorders in pregnant women are often untreated, leading to negative effects on maternal and fetal health. Objectives: The aim of this open-label pilot study is to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurzeck, Anna Katharina, Dechantsreiter, Esther, Wilkening, Anja, Kumpf, Ulrike, Nenov-Matt, Tabea, Padberg, Frank, Palm, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304475/
https://www.ncbi.nlm.nih.gov/pubmed/34356180
http://dx.doi.org/10.3390/brainsci11070947
_version_ 1783727344863674368
author Kurzeck, Anna Katharina
Dechantsreiter, Esther
Wilkening, Anja
Kumpf, Ulrike
Nenov-Matt, Tabea
Padberg, Frank
Palm, Ulrich
author_facet Kurzeck, Anna Katharina
Dechantsreiter, Esther
Wilkening, Anja
Kumpf, Ulrike
Nenov-Matt, Tabea
Padberg, Frank
Palm, Ulrich
author_sort Kurzeck, Anna Katharina
collection PubMed
description Introduction: Depression is the most common morbidity during pregnancy. Available first-line therapy options are limited and depressive disorders in pregnant women are often untreated, leading to negative effects on maternal and fetal health. Objectives: The aim of this open-label pilot study is to extend evidence on the use of transcranial direct current stimulation (tDCS) as a treatment of antenatal depression and to point out options for the use of tDCS in this population. Methods: Six drug-free female patients with major depressive disorder during pregnancy (later than 10th gestational week) were included in this pilot study. Patients were treated with twice-daily tDCS (2 mA, 30 min, anode: F3, cathode: F4) over ten days during inpatient stay (Phase 1) and with once-daily tDCS over 10 days during an optional outpatient stay (Phase 2). Clinical (HAMD-21, BDI) and neuropsychological ratings (Trail Making Test A/B) were performed at baseline, after two and four weeks as well as an obstetric examination. Results: Six right-handed females (23–43 years, 12–33. gestational week) completed Phase 1; four patients additionally joined in Phase 2. tDCS was well tolerated and no adverse effects occurred. Clinical ratings showed an improvement of mean baseline HAMD-21 from 22.50 ± 7.56 to 13.67 ± 3.93 after week 2, and to 8.75 ± 4.99 after week 4. The mean baseline BDI was 26.00 ± 13.90 and declined to 11.17 ± 5.46 after week 2, and to 9.25 ± 3.30 after week 4. Conclusions: Statistically significant changes in HAMD-21 and BDI were observed after Phase 1. One patient achieved remission in terms of HAMD in Phase 1. Although this small-scale study lacks sham control, it shows clinical improvement and absence of adverse events in this critical population.
format Online
Article
Text
id pubmed-8304475
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83044752021-07-25 Transcranial Direct Current Stimulation (tDCS) for Depression during Pregnancy: Results from an Open-Label Pilot Study Kurzeck, Anna Katharina Dechantsreiter, Esther Wilkening, Anja Kumpf, Ulrike Nenov-Matt, Tabea Padberg, Frank Palm, Ulrich Brain Sci Article Introduction: Depression is the most common morbidity during pregnancy. Available first-line therapy options are limited and depressive disorders in pregnant women are often untreated, leading to negative effects on maternal and fetal health. Objectives: The aim of this open-label pilot study is to extend evidence on the use of transcranial direct current stimulation (tDCS) as a treatment of antenatal depression and to point out options for the use of tDCS in this population. Methods: Six drug-free female patients with major depressive disorder during pregnancy (later than 10th gestational week) were included in this pilot study. Patients were treated with twice-daily tDCS (2 mA, 30 min, anode: F3, cathode: F4) over ten days during inpatient stay (Phase 1) and with once-daily tDCS over 10 days during an optional outpatient stay (Phase 2). Clinical (HAMD-21, BDI) and neuropsychological ratings (Trail Making Test A/B) were performed at baseline, after two and four weeks as well as an obstetric examination. Results: Six right-handed females (23–43 years, 12–33. gestational week) completed Phase 1; four patients additionally joined in Phase 2. tDCS was well tolerated and no adverse effects occurred. Clinical ratings showed an improvement of mean baseline HAMD-21 from 22.50 ± 7.56 to 13.67 ± 3.93 after week 2, and to 8.75 ± 4.99 after week 4. The mean baseline BDI was 26.00 ± 13.90 and declined to 11.17 ± 5.46 after week 2, and to 9.25 ± 3.30 after week 4. Conclusions: Statistically significant changes in HAMD-21 and BDI were observed after Phase 1. One patient achieved remission in terms of HAMD in Phase 1. Although this small-scale study lacks sham control, it shows clinical improvement and absence of adverse events in this critical population. MDPI 2021-07-19 /pmc/articles/PMC8304475/ /pubmed/34356180 http://dx.doi.org/10.3390/brainsci11070947 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kurzeck, Anna Katharina
Dechantsreiter, Esther
Wilkening, Anja
Kumpf, Ulrike
Nenov-Matt, Tabea
Padberg, Frank
Palm, Ulrich
Transcranial Direct Current Stimulation (tDCS) for Depression during Pregnancy: Results from an Open-Label Pilot Study
title Transcranial Direct Current Stimulation (tDCS) for Depression during Pregnancy: Results from an Open-Label Pilot Study
title_full Transcranial Direct Current Stimulation (tDCS) for Depression during Pregnancy: Results from an Open-Label Pilot Study
title_fullStr Transcranial Direct Current Stimulation (tDCS) for Depression during Pregnancy: Results from an Open-Label Pilot Study
title_full_unstemmed Transcranial Direct Current Stimulation (tDCS) for Depression during Pregnancy: Results from an Open-Label Pilot Study
title_short Transcranial Direct Current Stimulation (tDCS) for Depression during Pregnancy: Results from an Open-Label Pilot Study
title_sort transcranial direct current stimulation (tdcs) for depression during pregnancy: results from an open-label pilot study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304475/
https://www.ncbi.nlm.nih.gov/pubmed/34356180
http://dx.doi.org/10.3390/brainsci11070947
work_keys_str_mv AT kurzeckannakatharina transcranialdirectcurrentstimulationtdcsfordepressionduringpregnancyresultsfromanopenlabelpilotstudy
AT dechantsreiteresther transcranialdirectcurrentstimulationtdcsfordepressionduringpregnancyresultsfromanopenlabelpilotstudy
AT wilkeninganja transcranialdirectcurrentstimulationtdcsfordepressionduringpregnancyresultsfromanopenlabelpilotstudy
AT kumpfulrike transcranialdirectcurrentstimulationtdcsfordepressionduringpregnancyresultsfromanopenlabelpilotstudy
AT nenovmatttabea transcranialdirectcurrentstimulationtdcsfordepressionduringpregnancyresultsfromanopenlabelpilotstudy
AT padbergfrank transcranialdirectcurrentstimulationtdcsfordepressionduringpregnancyresultsfromanopenlabelpilotstudy
AT palmulrich transcranialdirectcurrentstimulationtdcsfordepressionduringpregnancyresultsfromanopenlabelpilotstudy